Acadia Healthcare (NASDAQ:ACHC) Rating Increased to Overweight at KeyCorp

Acadia Healthcare (NASDAQ:ACHC) was upgraded by stock analysts at KeyCorp from a “sector weight” rating to an “overweight” rating in a research report issued to clients and investors on Tuesday, MarketBeat reports. The firm presently has a $70.00 target price on the stock. KeyCorp’s price objective indicates a potential upside of 56.08% from the stock’s previous close.

Several other research firms have also recently weighed in on ACHC. Cantor Fitzgerald restated a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Royal Bank of Canada lowered their price target on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research report on Monday, November 18th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their target price for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Barclays lowered their price objective on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. Finally, StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $73.00.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $44.85 on Tuesday. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $87.77. The business’s fifty day moving average is $40.70 and its 200 day moving average is $58.54. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a market cap of $4.17 billion, a price-to-earnings ratio of 14.70, a PEG ratio of 1.77 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. The company had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.91 earnings per share. Research analysts predict that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Trading of Acadia Healthcare

Institutional investors have recently modified their holdings of the company. Point72 Asset Management L.P. increased its holdings in Acadia Healthcare by 266.0% during the 2nd quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock valued at $153,339,000 after purchasing an additional 1,650,040 shares during the period. Wellington Management Group LLP raised its holdings in shares of Acadia Healthcare by 12.2% during the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after acquiring an additional 1,266,384 shares in the last quarter. Millennium Management LLC lifted its stake in Acadia Healthcare by 3,067.8% in the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock worth $73,640,000 after acquiring an additional 1,055,894 shares during the period. Holocene Advisors LP boosted its holdings in Acadia Healthcare by 201.5% in the third quarter. Holocene Advisors LP now owns 972,513 shares of the company’s stock valued at $61,667,000 after acquiring an additional 649,997 shares in the last quarter. Finally, William Blair Investment Management LLC increased its position in Acadia Healthcare by 20.7% during the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after purchasing an additional 604,070 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.